Protein Supplement and Exercise Training for the Treatment of Malnutrition and Sarcopenia Risk in Older Adults (POWER)
Sarcopenia, Malnutrition
About this trial
This is an interventional treatment trial for Sarcopenia focused on measuring Older adults, Homecare, Community-dwelling, Malnutrition, Sarcopenia, Oral Nutritional Supplement, Resistance exercise
Eligibility Criteria
Inclusion Criteria: Older adults (70+ years) Requiring supportive homecare At risk of malnutrition (MNA-SF) At risk of sarcopenia (EWGSOP2) Exclusion Criteria: Cognitive impairment Severe kidney disease (glomerular filtration rate < 30 mL/min) Moderate to severe liver disease (Child-Pugh class B or C) Psychiatric disorder Receiving treatment or palliative care for cancer Receiving enteral or parenteral nutrition Hypersensitivity to any component of ONS Taking ONS Allergic to dairy products Regularly undertaking resistance (strength) training Advised by GP not to undertake physical activity
Sites / Locations
- UCD School of Public Health, Physiotherapy and Sports ScienceRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
(i) ONS + Exercise group
(ii) Exercise-alone group
This group will consume whey protein ONS enriched with leucine and vitamin D, twice a day for 12 weeks. The optimal time to consume the ONS on non-exercise days will be based on each participants 24-hour dietary recall. On exercise days, participants will be asked to consume the ONS after breakfast and after the exercise class. Participants will participate in a resistance-based exercise programme twice a week for 12 weeks which will be carried out over Zoom. Standard dietary advice to increase intake of protein, leucine and vitamin D using available literature designed for those at risk of malnutrition will be provided to this group by the research nutritionist.
Participants will participate in a resistance-based exercise programme twice a week for 12 weeks which will be carried out over Zoom. Standard dietary advice to increase intake of protein, leucine and vitamin D using available literature designed for those at risk of malnutrition will be provided to this group by the research nutritionist. The participants will not be provided with a placebo ONS.